Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

Immunostimulatory regimen comprising administering type 1 interferon and agonistic anti-CD40 antibody

US Patent 8361471 · Granted Jan 29, 2013

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I int2019
Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I int2019
Nucleic acid construct encoding an agonistic anti-CD40 antibody and a type I int2019
Immunostimulatory combinations2018
Methods and compositions for enhancing immune response2017
Immunotherapy comprising TLR9 ligand and CD40 ligand2015
Immunostimulatory regimen comprising administering type 1 interferon and agonist2015
Immunostimulatory regimen comprising administering type 1 interferon and agonist2015
Immunostimulatory regimen comprising administering type 1 interferon and agonist2015
Delivery of immune response modifier compounds2015
Ex vivo uses of immunostimulatory combinations2012
Immunostimulatory regimen comprising administering type 1 interferon and agonist2012